Skip to main content

Practice Management

Practice Management
The Value of Actionable Content in a Clinical Setting: Access to Better Information Facilitates Enhanced Cancer Care
A. Jacqueline Mitus, MD, Laura Coughlin, RN
Read More
Practice Management
The Economic Burden of Fragile X Syndrome: Healthcare Resource Utilization in the United States
Patricia Sacco, MPH, RPh, Gorana Capkun-Niggli, PhD, Xin Zhang, MS, Rosemary Jose, PhD, Michael F. Murphy, MD, PhD
Stakeholder Perspective
Rarity, Disease Heterogeneity, and a Pathway for Estimating Economic Burden
Read More
Practice Management
HIPAA Privacy and Security Regulations Updated
Ross D. Margulies, JD, MPH, Jayson Slotnik, JD, MPH
Read More
Practice Management
As Deadline Nears, Health Insurance Exchanges Making Progress, with Some Setbacks
Dalia Buffery, MA, ABD
Read More
Practice Management
Medicare Part D and the Federal Employees Health Benefits Program: A Comparison of Prescription Drug Coverage
Annesha Lovett, PharmD, MS, PhD, J. Warren Salmon, PhD, J. Warren Salmon, PhD
Stakeholder Perspective
Medicare Part D and the Federal Employees Health Benefits Program
Read More
Practice Management
Budget Impact Model: Epigenetic Assay Can Help Avoid Unnecessary Repeated Prostate Biopsies and Reduce Healthcare Spending
Wade Aubry, MD, Robert Lieberthal, PhD, Arnold Willis, MD, Grant Bagley, MD, Simon M. Willis III, MS, Andrew Layton, BA
Stakeholder Perspective
Molecular Epigenetic Tests Can Improve Clinical Outcomes While Reducing Healthcare Costs
by Kelly Huang, PhD
Read More
Practice Management
The Opportunity for Health Plans to Improve Quality and Reduce Costs by Embracing Primary Care Medical Homes
Sarah Collins, MBA, Kevin B. “Kip” Piper, MA, FACHE, Gary M. Owens, MD
Stakeholder Perspective
Enhancing Health Outcomes and Quality of Care with the Medical Home Model in Primary Care
by Jack E. Fincham, PhD, RPh
Read More
Practice Management
Current and Future Use of HEOR Data in Healthcare Decision-Making in the United States and in Emerging Markets
Anke-Peggy Holtorf, PhD, MBA, Diana Brixner, RPh, PhD, Brandon Bellows, PharmD, Abdulkadir Keskinaslan, MD, MBA, MPH, Joseph Dye, RPh, PhD, Gary Oderda, PharmD, MPH
Stakeholder Perspective
Health Economics and Outcomes Research Data Key in Coverage Decisions of New Medications
by Douglas S. Burgoyne, PharmD, FAMCP
Read More
Practice Management
The Policy-Driven Health Plan: A Road Map for Value-Based Reimbursement
James Evans
Read More
Practice Management
Hematologic Complications, Healthcare Utilization, and Costs in Commercially Insured Patients with Myelodysplastic Syndrome Receiving Supportive Care
Annette Powers, PharmD, MBA, Claudio Faria, PharmD, MPH, Eunice Chang, PhD, Dasha Cherepanov, PhD, Jeffrey A. Bourret, PharmD
Stakeholder Perspective
Reconsidering the Management of Younger Patients with Myelodysplastic Syndrome
Read More
Page 19 of 32
Results 181 - 190 of 318